27-01-2021 Announcement
The completion of the metallurgical test work and engineering studies to finalise the PFS based on a Kwinana operation is now expected in Q1 2021 (Jan to Mar 2021)
25-03-2021 Announcement
ENGINEERING STUDIES
Como Engineers’ Capex and Opex estimates are pending some final Vendor costings. Oncompletion, the PFS documentation will be finalised for release to the market
22-04-2021 Announcement
ENGINEERING STUDIES
Como Engineers’ Capex and Opex estimates are being finalised for incorporation into thePFS documentation.
30-04-2021 Announcement
ENGINEERING STUDIES
Como Engineers’ Capex and Opex estimates are pending some final modifications of theHPA washing circuit. On completion, the PFS documentation will be finalised forrelease to the market.
21-05-2021 Announcement
ENGINEERING STUDIES
Como Engineers have completed PFS level engineering studies to provide detailed capital and operating cost estimates. They are currently finalising the Engineering Report and the layout graphics for inclusion in the PFS report.
FINANCIAL MODELLING
FTI Consulting is completing the economic financial model for inclusion in the PFS report.
Como have completed studies but now they need to add layout graphics, something that wasn’t mentioned in any of the previous announcements. Also now FTI come into the equation, once again nothing mentioned about them before.
Come on KRR, Tony this has dragged out way too long now. The SP is showing people are fed up with the dates given from Q1 2021, to imminent etc. What is going to be the next thing to hold up the release of this PFS. Maybe drag it out to the new financial year or just before AGM??
- Forums
- ASX - By Stock
- KRR
- Ann: HPA Purity Verification
Ann: HPA Purity Verification, page-49
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KRR (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.28M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $1.344K | 134.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 5017473 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 364827 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 5017473 | 0.009 |
21 | 27795039 | 0.008 |
5 | 3681378 | 0.007 |
8 | 8989696 | 0.006 |
12 | 8038888 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 364827 | 4 |
0.011 | 3549692 | 6 |
0.012 | 1814039 | 8 |
0.013 | 2233363 | 5 |
0.014 | 1486416 | 5 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
KRR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online